Clariant AG/€CLN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Clariant AG
Clariant AG is a global specialty chemicals company headquartered in Muttenz, Switzerland. The company operates through several segments including Care Chemicals, Catalysis, and Natural Resources. Care Chemicals focus on consumer goods, industrial applications, as well as agriculture, offering products such as surfactants and polymers. Catalysis provides solutions for the petrochemical and refining industries, while Natural Resources cover oil and mining services. Founded in 1995 as a spin-off from Sandoz, Clariant has expanded its geographic footprint across Europe, North America, Latin America, and Asia. Its strategic strength lies in developing innovative and sustainable solutions aimed at enhancing customer performance, with a strong focus on R&D and bespoke product offerings.
- Ticker
- €CLN
- Sector
- Materials
- Primary listing
- XGAT
- Employees
- 10,107
- Headquarters
- Muttenz, Switzerland
- Website
- www.clariant.com
Clariant AG Metrics
BasicAdvanced
€3.8B
-
-€0.11
0.45
€0.46
3.98%
Price and volume
Market cap
€3.8B
Beta
0.45
52-week high
€11.90
52-week low
€7.18
Average daily volume
737K
Dividend rate
€0.46
Financial strength
Current ratio
1.77
Quick ratio
0.954
Long term debt to equity
0.826
Total debt to equity
0.977
Interest coverage (TTM)
6.02%
Profitability
EBITDA (TTM)
608.482
Gross margin (TTM)
30.98%
Net profit margin (TTM)
-0.82%
Operating margin (TTM)
9.58%
Effective tax rate (TTM)
100.22%
Revenue per employee (TTM)
€409,310
Management effectiveness
Return on assets (TTM)
3.83%
Return on equity (TTM)
-0.01%
Valuation
Price to revenue (TTM)
0.927
Price to book
1.74
Price to tangible book (TTM)
6.37
Price to free cash flow (TTM)
10.282
Free cash flow yield (TTM)
9.73%
Free cash flow per share (TTM)
1.119
Dividend yield (TTM)
3.98%
Growth
Revenue change (TTM)
-6.62%
Earnings per share change (TTM)
-129.44%
3-year revenue growth (CAGR)
-8.30%
10-year revenue growth (CAGR)
-4.21%
3-year earnings per share growth (CAGR)
-24.31%
10-year earnings per share growth (CAGR)
-17.25%
10-year dividend per share growth (CAGR)
0.49%
Bulls say / Bears say
Clariant showed pricing power and a more resilient mix in Q2: comparable sales rose 0.6% in local currency, while the EBITDA margin before exceptional items improved to 18.2%. Care Chemicals and Adsorbents & Additives more than offset the Catalysts setback. (Clariant)
There are credible growth options beyond the current downturn. Management expects a stronger second half as customers outside the Middle East resume operations, while new demand areas include syngas catalysts for lower-carbon plants and additives for data centres and renewable fuels. (Clariant, Yahoo Finance)
The underlying earnings trend is not yet clean. First-half EBITDA before exceptional items fell 7.7% and the margin slipped to 17.8%, while raw-material and energy costs rose; management’s 2026 guidance is only for flat sales in local currency. (Clariant)
Financial flexibility has weakened while the turnaround still carries execution costs. Net debt rose to CHF1.49 billion, taking net debt to EBITDA to 2.2 times from 2.0 times at 2025 year-end, and the expanded savings plan generated CHF29 million of one-off restructuring charges. (Clariant)
Data summarised monthly by Lightyear AI. Last updated on 22 Sept 2026.
Upcoming events
No upcoming events
Funds containing Clariant AG
AllEURGBPUSD
Fund name | Fund size | €CLN weighting |
|---|---|---|
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.17% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.17% |
Amundi STOXX Europe 600€MEUD | €7.6B | 0.02% |
Vanguard FTSE Global All-cap$VALU | $199M | 0.00% |
Vanguard FTSE Global All-cap€VGLA | €171M | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.